Group One Trading’s CorMedix CRMD Stock Holding History

Group One Trading’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$183K	Sell	27,000 -54,600	-67%	-$404K	﹤0.01%	4185
2025 Q4	$949K	Sell	81,600 -28,200	-26%	-$312K	﹤0.01%	2942
2025 Q3	$1.28M	Buy	109,800 +10,900	+11%	+$132K	﹤0.01%	2769
2025 Q2	$1.22M	Sell	98,900 -4,300	-4%	-$47.5K	﹤0.01%	2588
2025 Q1	$636K	Buy	103,200 +47,100	+84%	+$488K	﹤0.01%	2864
2024 Q4	$454K	Sell	56,100 -21,200	-27%	-$212K	﹤0.01%	3249
2024 Q3	$625K	Buy	77,300 +27,900	+56%	+$151K	﹤0.01%	2694
2024 Q2	$214K	Sell	49,400 -1,600	-3%	-$8.13K	﹤0.01%	3329
2024 Q1	$216K	Buy	51,000 +5,800	+13%	+$20.1K	﹤0.01%	3500
2023 Q4	$170K	Buy	45,200 +24,600	+119%	+$84.7K	﹤0.01%	4007
2023 Q3	$76.2K	Sell	20,600 -12,100	-37%	-$48.1K	﹤0.01%	4705
2023 Q2	$130K	Buy	32,700 +7,100	+28%	+$35.1K	﹤0.01%	4360
2023 Q1	$106K	Buy	25,600 +9,500	+59%	+$38.9K	﹤0.01%	4269
2022 Q4	$67.9K	Buy	16,100 +4,900	+44%	+$17.3K	﹤0.01%	4774
2022 Q3	$32K	Sell	11,200 -100	-0.9%	-$416	﹤0.01%	5748
2022 Q2	$45K	Buy	11,300 +6,300	+126%	+$23.4K	﹤0.01%	5652
2022 Q1	$27K	Buy	5,000 +400	+9%	+$1.83K	﹤0.01%	6543
2021 Q4	$21K	Sell	4,600 -30,800	-87%	-$153K	﹤0.01%	6942
2021 Q3	$165K	Buy	35,400 +1,000	+3%	+$5.82K	﹤0.01%	5368
2021 Q2	$236K	Buy	34,400 +13,700	+66%	+$109K	﹤0.01%	5052
2021 Q1	$207K	Buy	20,700 +5,200	+34%	+$54.7K	﹤0.01%	4992
2020 Q4	$115K	Buy	15,500 +100	+0.6%	+$680	﹤0.01%	4469
2020 Q3	$93K	Sell	15,400 -20,100	-57%	-$101K	﹤0.01%	4238
2020 Q2	$224K	Buy	35,500 +1,500	+4%	+$6.94K	﹤0.01%	3283
2020 Q1	$122K	Sell	34,000 -31,500	-48%	-$178K	﹤0.01%	3135
2019 Q4	$477K	Buy	65,500 +400	+0.6%	+$2.44K	﹤0.01%	2470
2019 Q3	$415K	Sell	65,100 -16,600	-20%	-$139K	﹤0.01%	2499
2019 Q2	$733K	Sell	81,700 -33,500	-29%	-$263K	0.01%	1814
2019 Q1	$1.09M	Buy	115,200 +104,720	+999%	+$944K	0.01%	1349
2018 Q4	$68K	Buy	+10,480	New	+$70.1K	﹤0.01%	3390
2018 Q3	–	Sell	-9,040	Closed	-$11K	–	5246
2018 Q2	$11K	Sell	9,040 -5,560	-38%	-$6.43K	﹤0.01%	4577
2018 Q1	$13K	Sell	14,600 -3,220	-18%	-$6.42K	﹤0.01%	4231
2017 Q4	$45K	Buy	17,820 +1,160	+7%	+$3.33K	﹤0.01%	3781
2017 Q3	$43K	Sell	16,660 -9,480	-36%	-$19.6K	﹤0.01%	3712
2017 Q2	$56K	Sell	26,140 -4,240	-14%	-$14.5K	﹤0.01%	3453
2017 Q1	$248K	Sell	30,380 -21,580	-42%	-$206K	﹤0.01%	2372
2016 Q4	$397K	Sell	51,960 -1,000	-2%	-$10.1K	﹤0.01%	1929
2016 Q3	$667K	Sell	52,960 -12,200	-19%	-$114K	0.01%	1593
2016 Q2	$648K	Sell	65,160 -7,800	-11%	-$119K	0.01%	1550
2016 Q1	$967K	Buy	72,960 +31,200	+75%	+$303K	0.01%	1199
2015 Q4	$424K	Buy	41,760 +8,800	+27%	+$101K	0.01%	1946
2015 Q3	$328K	Sell	32,960 -28,000	-46%	-$432K	﹤0.01%	2120
2015 Q2	$1.18M	Buy	60,960 +32,500	+114%	+$1.11M	0.02%	1086
2015 Q1	$1.4M	Buy	+28,460	New	+$675K	0.02%	838

Other funds holding CRMD

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Group One Trading's CRMD Position: Q1 2026 in Review

Group One Trading sold out of CorMedix (CRMD) in Q1 2026, closing a stake of 1,368 shares — an estimated $10.1K sold.

Group One Trading first reported a position in CRMD in Q1 2015 and held it in 35 quarters. The position peaked at $2.6M in Q3 2024. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

Group One Trading reported no remaining CorMedix position as of Q1 2026 after selling out during the quarter.
Group One Trading sold 1,368 CorMedix shares in Q1 2026, an estimated $10.1K.
Group One Trading first reported a position in CorMedix in Q1 2015 and held it in 35 quarters.
Group One Trading's CorMedix position peaked at $2.6M in Q3 2024.
187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.